Armata Pharmaceuticals, Inc.

ARMPAMEXHealthcare● Active

$7.56

+$0.06(+0.80%)

Market Cap$277533648

P/E Ratio—

52W High$16.34

52W Low$1.74

Avg Volume60K

Open$7.75

Beta1.22

Net Income Financials Revenue

Armata Pharmaceuticals, Inc. (ARMP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ARMP · net income · updated Jun 8, 2026

Core profitability metrics

ARMP · net income · margin · TTM · CAGR

Net income was −$173.8M for FY2025 (fiscal year ending 2025-12-31), down 818.8% year-over-year. Net profit margin was -3544.0%. Based on available data, Armata Pharmaceuticals, Inc. has been profitable since at least 2009.

FY2025 Net Income−$173.8M▼ -818.8% YoY

Trailing 12M (TTM)−$282.6Mtrailing 4 quarters sum

Net Profit Margin< −999%−$173.8M ÷ $4.9M

YoY Change-818.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2009

▸ FMP /income-statement · Annual · ARMP net income history · ARMP profit margin

Annual net income data

ARMP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$173.8M▼ 818.8%-3544.0%$4.9M

FY2024Loss−$18.9M▲ +72.6%-365.6%$5.2M

FY2023Loss−$69.0M▼ 87.0%-1524.5%$4.5M

FY2022Loss−$36.9M▼ 59.4%-670.2%$5.5M

FY2021Loss−$23.2M▼ 4.4%-517.5%$4.5M

Net income vs peers (Healthcare)

ARMP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Armata Pharmaceuticals, Inc.YOU

ARMP

−$173.8M-818.8%-3544.0%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Armata Pharmaceuticals, Inc. (ARMP) reported net income of −$173.8M for FY2025 (fiscal year ending 2025-12-31), down 818.8% year-over-year. The net profit margin was -3544.0% — meaning the company kept $-35.44 of every dollar of revenue as profit.

Based on available data, Armata Pharmaceuticals, Inc. has been profitable since at least 2009. Net income reached a peak of $23.1M in FY2014. Data available for 15 fiscal years.

Armata Pharmaceuticals, Inc.'s net profit margin was -3544.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Armata Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ARMP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ARMP net income · 4 questions

Armata Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $173.8M for FY2025.

is ARMP profitabledoes ARMP make a profitARMP profitabilityARMP profitable company

▸ Source: FMP /income-statement · GAAP · Armata Pharmaceuticals, Inc. · Armata Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026